Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Research and Markets: Updated Cardiovascular Drug Delivery Study - Examining Technological Innovation, Key Players and Markets (2010 to 2020)

Abstract:
Research and Markets has announced the addition of Jain PharmaBiotech's updated report "Cardiovascular Drug Delivery - Technologies, Markets and Companies" to their extensive offering of medical industry research publications.

Research and Markets: Updated Cardiovascular Drug Delivery Study - Examining Technological Innovation, Key Players and Markets (2010 to 2020)

Dublin, Ireland | Posted on October 4th, 2011

Advances in molecular pathophysiology of cardiovascular diseases have brought gene therapy within the realm of possibility as a novel approach to treatment. Gene therapy is not only a sophisticated method of drug delivery, it may in time need drug delivery devices such as catheters for transfer of genes to various parts of the cardiovascular system.

Cardiovascular Drug Delivery - Technologies, Markets and Companies begins by introducing molecular cardiology and examines its relationship to biotechnology and drug delivery systems. Analysis of drug delivery is provided at three levels:

routes of drug delivery
formulations
applications to various diseases

Complete sections in Cardiovascular Drug Delivery - Technologies, Markets and Companies are devoted to cell and gene therapies, including antisense and RNA interference, as they are currently at the cutting edge of therapeutics delivery methodology. Various methods of improving systemic administration of drugs for cardiovascular disorders are described including use of nanotechnology.

One of the most exciting areas of biomedical engineering is cell-selective drug delivery, which involves the optimising the therapeutic efficacy of a drug by strictly localizing its pharmacological activity to a pathophysiologically relevant tissue system. Jain PharmaBiotech applies these concepts to targeted drug delivery to the cardiovascular system, while devices for drug delivery to the cardiovascular system are also examined.

The role of drug delivery in various cardiovascular disorders such as myocardial ischemia, hypertension and hypercholesterolemia is discussed, as is cardioprotection. A full chapter is devoted to drug-eluting stents as treatment for restenosis following stenting of coronary arteries.

The treatment of heart disease is being improved with the development of emerging cell-based therapeutic strategies. Cell grafting or mobilizing endogenous cells are potentially, particularly fruitful for heart repair - where the slight capacity for cardiomyocyte proliferation probably contributes to the irreversibility of heart failure. Cell therapy approaches include attempts to reinitiate cardiomyocyte proliferation in the adult, conversion of fibroblasts to contractile myocytes, conversion of bone marrow stem cells into cardiomyocytes, and transplantation of myocytes or other cells into injured myocardium.

The cardiovascular drug delivery markets are estimated for the years 2010 to 2020 on the basis of epidemiology and total markets for cardiovascular therapeutics. Markets for drug-eluting stents are calculated separately.

Key Topics Covered:

Cardiovascular Diseases
Methods for Drug Delivery to the Cardiovascular System
Cell Therapy for Cardiovascular Disorders
Gene Therapy for Cardiovascular Disorders
Drug-Eluting Stents
Markets for Cardiovascular Drug Delivery
Companies involved in Cardiovascular Drug Delivery
Profiles of companies
Collaborations
References

####

For more information, please click here

Contacts:
Research and Markets
Laura Wood, Senior Manager
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

A new product to help combat mouldy walls, thanks to technology developed at the ICN2 December 14th, 2017

Sandia researchers make solid ground toward better lithium-ion battery interfaces: Reducing the traffic jam in batteries December 13th, 2017

Perking up and crimping the 'bristles' of polyelectrolyte brushes December 13th, 2017

Columbia engineers create artificial graphene in a nanofabricated semiconductor structure: Researchers are the first to observe the electronic structure of graphene in an engineered semiconductor; finding could lead to progress in advanced optoelectronics and data processing December 13th, 2017

Nanomedicine

Perking up and crimping the 'bristles' of polyelectrolyte brushes December 13th, 2017

Leti to Demo Wristband with Embedded Sensors to Diagnose Sleep Apnea: APNEAband, Which Will Be Demonstrated at CES 2018, Also Monitors Mountain Sickness, Dehydration, Dialysis Treatment Response and Epileptic Seizures December 12th, 2017

Untangling DNA: Researchers filter the entropy out of nanopore measurements December 8th, 2017

Arrowhead Presents New Clinical Data Demonstrating a Sustained Host Response in Hepatitis B Patients Following RNAi Therapy Up to 5.0 log10 reduction in HBsAg observed; data presented at HEP DART 2017 December 6th, 2017

Announcements

A new product to help combat mouldy walls, thanks to technology developed at the ICN2 December 14th, 2017

Sandia researchers make solid ground toward better lithium-ion battery interfaces: Reducing the traffic jam in batteries December 13th, 2017

Perking up and crimping the 'bristles' of polyelectrolyte brushes December 13th, 2017

Columbia engineers create artificial graphene in a nanofabricated semiconductor structure: Researchers are the first to observe the electronic structure of graphene in an engineered semiconductor; finding could lead to progress in advanced optoelectronics and data processing December 13th, 2017

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers

UCLA chemists synthesize narrow ribbons of graphene using only light and heat: Tiny structures could be next-generation solution for smaller electronic devices December 8th, 2017

Device makes power conversion more efficient: New design could dramatically cut energy waste in electric vehicles, data centers, and the power grid December 8th, 2017

Creating a new kind of metallic glass December 7th, 2017

Copper will replace toxic palladium and expensive platinum in the synthesis of medications: The effectiveness of copper nanoparticles as a catalyst has been proven December 5th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project